Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
- PMID: 11279497
- DOI: 10.1038/35069076
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Erratum in
- Nature 2001 Jun 21;411(6840):974
Abstract
Marijuana affects brain function primarily by activating the G-protein-coupled cannabinoid receptor-1 (CB1), which is expressed throughout the brain at high levels. Two endogenous lipids, anandamide and 2-arachidonylglycerol (2-AG), have been identified as CB1 ligands. Depolarized hippocampal neurons rapidly release both anandamide and 2-AG in a Ca2+-dependent manner. In the hippocampus, CB1 is expressed mainly by GABA (gamma-aminobutyric acid)-mediated inhibitory interneurons, where CB1 clusters on the axon terminal. A synthetic CB1 agonist depresses GABA release from hippocampal slices. These findings indicate that the function of endogenous cannabinoids released by depolarized hippocampal neurons might be to downregulate GABA release. Here we show that the transient suppression of GABA-mediated transmission that follows depolarization of hippocampal pyramidal neurons is mediated by retrograde signalling through release of endogenous cannabinoids. Signalling by the endocannabinoid system thus represents a mechanism by which neurons can communicate backwards across synapses to modulate their inputs.
Similar articles
-
Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.J Neurophysiol. 2008 Aug;100(2):1041-52. doi: 10.1152/jn.90226.2008. Epub 2008 May 21. J Neurophysiol. 2008. PMID: 18497350 Free PMC article.
-
Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.Neuroscience. 2001;106(1):1-4. doi: 10.1016/s0306-4522(01)00287-1. Neuroscience. 2001. PMID: 11564411
-
Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus.Eur J Neurosci. 2003 Aug;18(3):524-34. doi: 10.1046/j.1460-9568.2003.02773.x. Eur J Neurosci. 2003. PMID: 12911748
-
Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition.Chem Phys Lipids. 2002 Dec 31;121(1-2):73-82. doi: 10.1016/s0009-3084(02)00149-4. Chem Phys Lipids. 2002. PMID: 12505692 Review.
-
Endocannabinoid signaling in the brain.Science. 2002 Apr 26;296(5568):678-82. doi: 10.1126/science.1063545. Science. 2002. PMID: 11976437 Review.
Cited by
-
Neurotransmitters, Cell Types, and Circuit Mechanisms of Motor Skill Learning and Clinical Applications.Front Neurol. 2021 Feb 25;12:616820. doi: 10.3389/fneur.2021.616820. eCollection 2021. Front Neurol. 2021. PMID: 33716924 Free PMC article. Review.
-
Endocannabinoid-mediated neuromodulation in the main olfactory bulb at the interface of environmental stimuli and central neural processing.Eur J Neurosci. 2022 Feb;55(4):1002-1014. doi: 10.1111/ejn.15186. Epub 2021 Apr 2. Eur J Neurosci. 2022. PMID: 33724578 Free PMC article. Review.
-
Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats.Psychopharmacology (Berl). 2020 Dec;237(12):3729-3739. doi: 10.1007/s00213-020-05650-5. Epub 2020 Aug 28. Psychopharmacology (Berl). 2020. PMID: 32857187 Free PMC article.
-
CBD lengthens sleep but shortens ripples and leads to intact simple but worse cumulative memory.iScience. 2023 Oct 24;26(11):108327. doi: 10.1016/j.isci.2023.108327. eCollection 2023 Nov 17. iScience. 2023. PMID: 38026151 Free PMC article.
-
Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.Future Med Chem. 2012 Feb;4(2):187-204. doi: 10.4155/fmc.11.179. Future Med Chem. 2012. PMID: 22300098 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous